The global Synthetic Absorbable Sutures market garnered revenue around USD 3.15 billion in 2025 and projected to reach USD 7.54 billion in 2035, with at a compound annual growth rate (CAGR) 9.12% throughout the estimate period from 2026 to 2035.

Synthetic absorbable sutures are widely used in surgical procedures due to their ability to maintain wound closure without the need for removal. These sutures are made from synthetic polymers such as polyglactin, polyglycolic acid, and polydioxanone. They are gradually absorbed by the body over a period of time, which eliminates the need for a follow-up procedure to remove the sutures. These sutures are critical in various medical disciplines, including general surgery, ophthalmology, gynecology, orthopedic surgery, and more.
The synthetic absorbable sutures market has evolved with medical technology, with improvements in the materials used and their effectiveness in wound closure. The increasing incidence of surgical procedures, particularly in developed regions, coupled with growing healthcare access in emerging economies, has contributed significantly to the market’s expansion.
In addition to being cost-effective, synthetic absorbable sutures reduce the risk of infection, as their absorption reduces the likelihood of foreign body reactions compared to non-absorbable sutures. This market is witnessing advancements driven by the need for better performance, stronger knots, and reduced tissue reactions, thus enhancing the post-operative recovery process.
The synthetic absorbable sutures market is being shaped by several key trends:
| Report Coverage | Details |
| Market Size in 2026 | USD 3.44 Billion |
| Market Size by 2035 | USD 7.54 Billion |
| Growth Rate From 2026 to 2035 | CAGR of 9.12% |
| Base Year | 2025 |
| Forecast Period | 2026 to 2035 |
| Segments Covered | By Product Type, By Material, By Application, By End User, By Regional |
| Market Analysis (Terms Used) | Value (USD Million/Billion) or (Volume/Units) |
| Regional Scope | North America; Europe; Asia Pacific; Central and South America; the Middle East and Africa |
| Key Companies Profiled | Braun Melsungen AG,, Medtronic plc, Teleflex Incorporated, Johnson & Johnson, Smith & Nephew plc, Acelity L.P. Inc., Boston Scientific Corporation, Zimmer Biomet Holdings, Inc., ConMed Corporation, Integra LifeSciences Corporation |
One of the key drivers propelling the growth of the synthetic absorbable sutures market is the increasing number of surgical procedures globally. The demand for surgeries, particularly in fields such as orthopedics, cardiovascular, and gynecology, has been growing due to an aging population and a rise in chronic diseases such as cardiovascular ailments, diabetes, and musculoskeletal disorders. According to the World Health Organization (WHO), the global burden of chronic diseases continues to rise, contributing to the demand for surgical interventions, thus driving the need for absorbable sutures.
Moreover, the global increase in cosmetic and reconstructive surgeries has created a greater demand for specialized sutures. With synthetic absorbable sutures offering various advantages like eliminating the need for removal and promoting better healing, their usage in both elective and emergency surgeries is expanding. This growing volume of surgeries creates a robust demand for advanced suturing solutions like synthetic absorbable sutures, thereby supporting market growth.
While synthetic absorbable sutures offer numerous advantages, one of the key restraints is the high cost associated with advanced sutures, especially those made from premium materials. Compared to traditional non-absorbable sutures, synthetic absorbable sutures are generally more expensive. For hospitals and clinics, this added cost can be significant, particularly in cost-sensitive regions. The preference for more affordable options, especially in developing economies, has limited the adoption of high-end synthetic absorbable sutures.
Additionally, the longer shelf life of non-absorbable sutures, coupled with their relatively lower cost, can make them more appealing in certain surgeries where absorbable sutures are not strictly necessary. This cost disparity creates a barrier for wider adoption, particularly in price-sensitive markets, which could restrain market growth.
One of the most significant opportunities for the synthetic absorbable sutures market lies in the growing trend of minimally invasive surgeries (MIS). MIS techniques, including laparoscopy and arthroscopy, are gaining popularity as they offer reduced recovery times, less pain, and smaller incisions. The demand for sutures that support wound closure in these minimally invasive procedures is increasing.
Minimally invasive procedures require highly specialized sutures that can support the healing process while being absorbed by the body. Synthetic absorbable sutures meet these needs, providing secure closure without requiring a second procedure to remove the sutures. With the global shift toward less invasive treatment options, the demand for synthetic absorbable sutures is poised to grow.
How did the polyglactin sutures segment dominate the Global Synthetic Absorbable Sutures market?
The polyglactin sutures segment is driven by a superior performance profile, combining high tensile strength with a predictable absorption rate. Its exceptional versatility and clinical trust have established it as the standard of care across general, orthopaedic, and gynaecological surgeries. Its balanced reliability and safety ensure it remains the dominant choice for practitioners over specialized alternatives.
How did the polydioxanone (PDO) sutures segment expect to hold the fastest-growing Global Synthetic Absorbable Sutures market in the coming years?
The polydioxanone (PDO) sutures segment is driven by the rapid adoption of innovations, such as barbed technology and antimicrobial coatings that enhance surgical efficiency and patient safety. The surge in minimally invasive surgeries and aesthetic medicine continues to drive high demand for PDO’s reliable, monofilament performance. Its superior long-term tensile strength, which is essential for complex orthopedic and cardiovascular procedures in an aging population.
How did the braided sutures segment account for the largest share in the Global Synthetic Absorbable Sutures market?
The braided sutures segment is driven by offering superior handling flexibility and exceptional knot security compared to monofilament alternatives. Its high tensile strength and advanced coatings reduce tissue drag and infection risks, making it the primary choice for high-tension closures in general and cardiovascular surgeries.
How did the monofilament sutures segment expect to hold the fastest-growing Global Synthetic Absorbable Sutures market in the coming years?
The monofilament sutures segment is driven by its smooth, single-strand structure that minimizes tissue trauma and inflammation in delicate procedures. Their unique design reduces infection risk by eliminating capillary spaces where bacteria can harbour, a critical advantage for modern surgical safety. As minimally invasive surgery becomes the standard, the superior handling and innovative coatings of monofilaments, such as polydioxanone, ensure they meet the demands of high-precision clinical environments.
The cardiovascular sutures segment dominates the application segment, driven by the rising number of heart-related surgeries globally. Cardiovascular diseases continue to be a leading cause of mortality, particularly in developed regions, contributing to the strong demand for effective sutures.
At the same time, cosmetic surgery sutures are expected to be the fastest-growing segment, fueled by the increasing popularity of elective surgeries like facelifts, liposuction, and breast augmentation. The desire for enhanced aesthetics, particularly in developed markets, is pushing this growth, with patients seeking advanced, absorbable sutures for minimal scarring.
How did the hospitals segment account for the largest share in the Global Synthetic Absorbable Sutures market?
The hospitals segment is driven by the rising global volume of joint replacements, spinal surgeries, and critical heart procedures. The transition toward advanced synthetic polymers offers the superior tensile strength and predictable absorption required for internal tissue closure. The shift toward robotic-assisted and minimally invasive surgeries has made high-performance, bioabsorbable materials indispensable for modern recovery protocols.
How did the ambulatory surgical centers segment expect to hold the fastest-growing Global Synthetic Absorbable Sutures market in the coming years?
The ambulatory surgical centers segment is driven by the preference for high-performance synthetic materials like polyglactin 910 and polydioxanone, which offer the predictable absorption and superior tensile strength essential for same-day recovery. The expansion of Medicare-certified facilities and the adoption of minimally invasive techniques solidify ASCs as a primary engine for synthetic suture demand.
Raw Material Procurement and Polymer Synthesis
This stage involves the production of synthetic polymers such as Polyglactin 910, Poliglecaprone 25, Polydioxanone (PDO), and Polyglycolic acid (PGA) through chemical synthesis, often utilizing ring-opening polymerization of dimers.
Suture Manufacturing and Processing
Manufacturers take the raw polymers and convert them into suture threads through extrusion, drawing, stretching, and either braiding (multifilament) or monofilament formation.
Distribution and Logistics
This stage involves the distribution of the finished sterile sutures to end-users, managed through direct sales forces, distributors, and logistics partners.
By Product Type
By Material
By Application
By End User
By Regional